But the proposals ... NICE clinical guidelines don’t have the same funding requirements). As mentioned earlier, Sovaldi first presented a major problem of a cost-effective drug that was at ...

In the U.S. patient out-of-pocket costs for prescription drugs ... cost to the plan and the number of close substitutes. Ideally, formulary design is value-based in the sense that the most cost ...

A polypill for preventing cardiovascular disease has the potential to address health inequities and expand health care access ...

Hochul said she also would work with other states to leverage their combined purchasing power to reduce the cost of the drugs for all New Yorkers. Details of the proposal are expected Tuesday ...